Sublimity Therapeutics Funding: $75M Raised, Series B (2021)
Sublimity Therapeutics is based in Dublin, Ireland. It has raised $75M in total funding. Latest round: Series B.
Sublimity Therapeutics funding overview
Sublimity Therapeutics is based in Dublin, Ireland. Sublimity Therapeutics has raised $75M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in May 2021. The round record for Sublimity Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include OrbiMed, Longitude Capital, HBM Healthcare Investments. 3 distinct backers are named across the disclosed rounds.
Frequently asked about Sublimity Therapeutics funding
How much has Sublimity Therapeutics raised?
Sublimity Therapeutics has raised $75M in total disclosed funding across the rounds on record.
Who has invested in Sublimity Therapeutics?
OrbiMed, Longitude Capital, HBM Healthcare Investments are named among the investors backing Sublimity Therapeutics.
What was the latest Sublimity Therapeutics funding round?
The most recent disclosed round is a Series B, announced in May 2021.
Where is Sublimity Therapeutics based?
Sublimity Therapeutics is based in Dublin, Ireland.
When did Sublimity Therapeutics last raise?
The last disclosed Sublimity Therapeutics round closed in May 2021 at Series B.
Round data for Sublimity Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Dublin and backer lists below.
